Movatterモバイル変換


[0]ホーム

URL:


Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
Thehttps:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

NIH NLM Logo
Log inShow account info
Access keysNCBI HomepageMyNCBI HomepageMain ContentMain Navigation
pubmed logo
Advanced Clipboard
User Guide

Full text links

MDPI full text link MDPI Free PMC article
Full text links

Actions

Share

Review
.2021 Nov 2;9(11):2282.
doi: 10.3390/microorganisms9112282.

Diabetes-Associated Susceptibility to Tuberculosis: Contribution of Hyperglycemia vs. Dyslipidemia

Affiliations
Review

Diabetes-Associated Susceptibility to Tuberculosis: Contribution of Hyperglycemia vs. Dyslipidemia

Minh Dao Ngo et al. Microorganisms..

Abstract

Diabetes is a major risk factor for tuberculosis (TB). Diabetes increases the risk of the progression from latent tuberculosis infection (LTBI) to active pulmonary TB and TB patients with diabetes are at greater risk of more severe disease and adverse TB treatment outcomes compared to TB patients without co-morbidities. Diabetes is a complex disease, characterised not only by hyperglycemia but also by various forms of dyslipidemia. However, the relative contribution of these underlying metabolic factors to increased susceptibility to TB are poorly understood. This review summarises our current knowledge on the epidemiology and clinical manifestation of TB and diabetes comorbidity. We subsequently dissect the relative contributions of body mass index, hyperglycemia, elevated cholesterol and triglycerides on TB disease severity and treatment outcomes. Lastly, we discuss the impact of selected glucose and cholesterol-lowering treatments frequently used in the management of diabetes on TB treatment outcomes.

Keywords: Mycobacterium tuberculosis; cholesterol; diabetes; dyslipidemia; hyperglycemia; triglycerides; tuberculosis.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Schematic overview of the impact of cholesterol, triglycerides, hyperglycemia and BMI on risk of active TB, TB disease severity and treatment outcomes. Created withBioRender.com.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Cohen A., Mathiasen V.D., Schön T., Wejse C. The global prevalence of latent tuberculosis: A systematic review and meta-analysis. Eur. Respir. J. 2019;54:1900655. doi: 10.1183/13993003.00655-2019. - DOI - PubMed
    1. World Health Organization . Global Tuberculosis Report 2020. World Health Organization; Geneva, Switzerland: 2020.
    1. Federation I.D. IDF Diabetes Atlas. [(accessed on 22 September 2021)]. Available online:https://www.diabetesatlas.org.
    1. McMurry H.S., Mendenhall E., Rajendrakumar A., Nambiar L., Satyanarayana S., Shivashankar R. Coprevalence of type 2 diabetes mellitus and tuberculosis in low-income and middle-income countries: A systematic review. Diabetes Metab. Res. Rev. 2019;35:e3066. doi: 10.1002/dmrr.3066. - DOI - PubMed
    1. World Health Organization . The Impact of the COVID-19 Pandemic on Noncommunicable Disease Resources and Services: Results of a Rapid Assessment. World Health Organization; Geneva, Switzerland: 2020.

Publication types

Related information

Grants and funding

LinkOut - more resources

Full text links
MDPI full text link MDPI Free PMC article
Cite
Send To

NCBI Literature Resources

MeSHPMCBookshelfDisclaimer

The PubMed wordmark and PubMed logo are registered trademarks of the U.S. Department of Health and Human Services (HHS). Unauthorized use of these marks is strictly prohibited.


[8]ページ先頭

©2009-2025 Movatter.jp